Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
MicroPort CardioFlow Medtech Corp. ( (HK:2160) ) just unveiled an update.
MicroPort CardioFlow Medtech Corp. announced the results of its Annual General Meeting held on June 27, 2025, where all proposed resolutions were approved by shareholders. The meeting also marked the retirement of an independent non-executive director and the appointment of a new one, leading to changes in the composition of the board committees. These developments are expected to influence the company’s governance and strategic direction, potentially impacting its market position and stakeholder relationships.
More about MicroPort CardioFlow Medtech Corp.
MicroPort CardioFlow Medtech Corp. is a company incorporated in the Cayman Islands, focusing on the medical technology industry. It specializes in cardiovascular devices and solutions, aiming to enhance treatment options for heart-related conditions.
Average Trading Volume: 5,526,959
Technical Sentiment Signal: Sell
Current Market Cap: HK$2.2B
For an in-depth examination of 2160 stock, go to TipRanks’ Overview page.